* P3 Health Partners Inc PIII.OQ PIII.O is expected
to show a
rise in quarterly revenue when it reports results on May 10.
* The Chicago Illinois-based company is expected to report
a
3.4% increase in revenue to $282.898 million from $273.54
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for P3 Health Partners
Inc is
for a loss of 67 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for P3 Health
Partners Inc is $5.5, above its last closing price of $1.93.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.91 -2.26 Missed -148.4
Sep. 30 2022 -0.47 -0.46 -0.27 Beat 41.7
Jun. 30 2022 -0.16 -0.21 Missed -31.2
Mar. 31 2022 -0.12 -0.25 Missed -102.7
Dec. -0.24 -0.24 Met 1.4
31 2021
This summary was machine generated May 9 at 02:03 GMT. All
figures in US dollars unless otherwise stated